デフォルト表紙
市場調査レポート
商品コード
1378754

腎デナベーションシステム市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
腎デナベーションシステム市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

腎デナベーションシステムの世界市場規模は2022年に3億1,800万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに23億6,200万米ドルに達し、2022年から2028年の間に39.7%の成長率(CAGR)を示すと予測しています。

腎デナベーション(RDN)は、カテーテルを用いた腎動脈壁内の交感神経のアブレーションを伴う介入手技です。神経を最大限に遮断し、レニン分泌を低下させ、ナトリウム利尿を促し、腎血行動態または血流を改善します。その結果、RDNシステムは、至適治療では患者を救済できない難治性高血圧症例の治療に広く使用されています。

喫煙や飲酒をする人の増加、不健康な食事パターンの増加、座りがちで多忙なライフスタイル、高齢者人口の増加などを背景に、高血圧などの生活習慣病の有病率が大幅に上昇していることが、市場の成長を強める主な要因の1つとなっています。これとは別に、迅速な回復、安全性、時間効率、費用対効果など、RDNシステムに関連する利点が、もう一つの主要な成長誘発要因として作用しています。さらに、低侵襲(MI)手術に対する需要の高まりも市場の成長に寄与しています。マイクロインフュージョン技術のイントロダクション、ヘルスケアインフラの改善、研究開発(R&D)活動の活発化、システムの薬事承認申請件数の増加なども市場成長に好影響を与えています。しかし、コロナウイルス感染症(COVID-19)の急増による病院受診の減少や選択的医療処置の再スケジュールが市場成長に影響を与えています。

本レポートで扱う主な質問

  • 腎デナベーションシステムの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • 主要な地域市場は?
  • COVID-19が世界の腎デナベーションシステム市場に与えた影響は?
  • 製品タイプ別の市場内訳は?
  • 製品別の市場内訳は?
  • 技術別の市場内訳は?
  • 用途別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主要な促進要因と課題は何か?
  • 世界の腎デナベーションシステムの市場構造と主要プレイヤーは?
  • 業界における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 腎デナベーションシステムの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • カテーテル
    • 市場動向
    • 主要タイプ
      • 単一電極カテーテル
      • 多電極カテーテル
    • 市場予測
  • RFジェネレーター
    • 市場動向
    • 市場予測
  • 神経修飾剤
    • 市場動向
    • 市場予測

第7章 市場内訳:製品別

  • シンプリシティ
    • 市場動向
    • 市場予測
  • ベシックス(V2)
    • 市場動向
    • 市場予測
  • エンリグHTN
    • 市場動向
    • 市場予測
  • パラダイス
    • 市場動向
    • 市場予測
  • イベリス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:技術別

  • 超音波アブレーション
    • 市場動向
    • 市場予測
  • 高周波アブレーション
    • 市場動向
    • 市場予測
  • マイクロインフュージョン
    • 市場動向
    • 市場予測

第9章 市場内訳:用途別

  • 高血圧
    • 市場動向
    • 市場予測
  • 心臓疾患
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • 腎不全
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:エンドユーザー別

  • 診断センター、病院
    • 市場動向
    • 市場予測
  • 外来医療センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boston Scientific Group
    • Kona Medical Inc.
    • Medtronic Plc
    • Mercator MedSystems
    • ReCor Medical Inc.(Otsuka Holdings Co. Ltd.)
    • Renal Dynamics
    • St. Jude Medical Inc.(Abbott)
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
  • Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
  • Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Renal Denervation Systems Market Structure
  • Table 9: Global: Renal Denervation Systems Market: Key Players
目次
Product Code: SR112023A2558

Abstract

The global renal denervation systems market size reached US$ 318 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,362 Million by 2028, exhibiting a growth rate (CAGR) of 39.7% during 2022-2028.

Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.

A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. The introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are also creating a positive influence on the market growth. Although, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) have impacted the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, product, technology, application and end user.

Breakup by Product Type:

Catheters

Single Electrode Catheter

Multi Electrode Catheter

RF Generator

Nerve Modifying Agents

Breakup by Product:

Symplicity

Vessix (V2)

EnligHTN

Paradise

Iberis

Others

Breakup by Technology:

Ultrasound Ablation

Radiofrequency Ablation

Microinfusion

Breakup by Application:

Hypertension

Cardiac Disorders

Diabetes

Renal Failure

Others

Breakup by End User:

Diagnostic Centers and Hospitals

Ambulatory Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global renal denervation systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global renal denervation systems market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global renal denervation systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Catheters
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Single Electrode Catheter
      • 6.1.2.2 Multi Electrode Catheter
    • 6.1.3 Market Forecast
  • 6.2 RF Generator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nerve Modifying Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Symplicity
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vessix (V2)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 EnligHTN
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Paradise
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Iberis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Ultrasound Ablation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Radiofrequency Ablation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microinfusion
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hypertension
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiac Disorders
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diabetes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Renal Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Diagnostic Centers and Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Care Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Boston Scientific Group
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Kona Medical Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Medtronic Plc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Mercator MedSystems
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Renal Dynamics
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 St. Jude Medical Inc. (Abbott)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Terumo Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis